SPARCL1 and gastrointestinal stromal tumor: In vitro and in vivo experiments suggested that downregulation of SPARCL1 significantly enhanced the invasion and liver metastasis ability of GIST 882 cell, but did not influence the GIST cell proliferation, cell cycle, and apoptosis.